AU1243101A - High dose folic acid for the treatment of hyperhomocysteinemia - Google Patents
High dose folic acid for the treatment of hyperhomocysteinemiaInfo
- Publication number
- AU1243101A AU1243101A AU12431/01A AU1243101A AU1243101A AU 1243101 A AU1243101 A AU 1243101A AU 12431/01 A AU12431/01 A AU 12431/01A AU 1243101 A AU1243101 A AU 1243101A AU 1243101 A AU1243101 A AU 1243101A
- Authority
- AU
- Australia
- Prior art keywords
- hyperhomocysteinemia
- treatment
- folic acid
- high dose
- dose folic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 title 2
- 208000033892 Hyperhomocysteinemia Diseases 0.000 title 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 title 1
- 229960000304 folic acid Drugs 0.000 title 1
- 235000019152 folic acid Nutrition 0.000 title 1
- 239000011724 folic acid Substances 0.000 title 1
- 230000003225 hyperhomocysteinemia Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16190899P | 1999-10-28 | 1999-10-28 | |
US60161908 | 1999-10-28 | ||
PCT/US2000/029788 WO2001030352A1 (en) | 1999-10-28 | 2000-10-30 | High dose folic acid for the treatment of hyperhomocysteinemia |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1243101A true AU1243101A (en) | 2001-05-08 |
Family
ID=22583314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU12431/01A Abandoned AU1243101A (en) | 1999-10-28 | 2000-10-30 | High dose folic acid for the treatment of hyperhomocysteinemia |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1243101A (en) |
WO (1) | WO2001030352A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2851920B1 (en) * | 2003-03-06 | 2007-05-04 | Larena Sa | PRODUCT FOR REDUCING METABOLIC SYNDROME AND USE THEREOF FOR THE PREPARATION OF A FOOD OR DIETETIC COMPOSITION FOR THE PREVENTION OR TREATMENT OF METABOLIC SYNDROME |
DE10357277A1 (en) * | 2003-12-05 | 2005-06-30 | Phyt-Immun Gmbh | Agent for improving iron absorption |
US20070249729A1 (en) * | 2003-12-18 | 2007-10-25 | Urquhart Bradley L | Method of Treating Elevated Plasma Homocysteine Levels in Esrd Patients |
US20060217386A1 (en) * | 2005-03-10 | 2006-09-28 | Edwards John B | Nutritional preparations |
US8859235B2 (en) * | 2009-08-14 | 2014-10-14 | Basf Se | Methods in cell cultures, and related inventions, employing certain additives |
EP2808023A1 (en) * | 2013-05-30 | 2014-12-03 | Université Pierre et Marie Curie (Paris 6) | New drug for the treatment and/or prevention of depressive disorders |
WO2020092616A1 (en) * | 2018-10-31 | 2020-05-07 | Rejuvenation Therapeutics | Compositions useful in the treatment of hyperhomocysteinemia |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06192105A (en) * | 1992-09-14 | 1994-07-12 | Vesta Medicines Pty Ltd | Medical preparation for lowering level of homocysteine |
US6008221A (en) * | 1996-11-06 | 1999-12-28 | Bristol-Myers Squibb Company | Method for treating Alzheimer's disease with folic acid |
US6054128A (en) * | 1997-09-29 | 2000-04-25 | Wakat; Diane | Dietary supplements for the cardiovascular system |
-
2000
- 2000-10-30 WO PCT/US2000/029788 patent/WO2001030352A1/en active Application Filing
- 2000-10-30 AU AU12431/01A patent/AU1243101A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001030352A1 (en) | 2001-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200107122B (en) | Treatment of acne using lipoic acid. | |
AU2003258848A1 (en) | Hyaluronic acid derivatives and processes for preparing the same | |
HUP0204399A3 (en) | Pteridine compounds for the treatment of psoriasis, process for their preparation, pharmaceutical compositions containing them and their use | |
IL141295A0 (en) | Use of derivatives of aryl (or heteroaryl) azolycarbinols in the manufacture of a medicament for the treatment of disorders mediated by an excess of substance p | |
AU6910600A (en) | Methods for the treatment of mental disorders | |
AU7622000A (en) | Compounds for the treatment of viral-mediated diseases | |
AU2002240359A1 (en) | Pharmaceutical composition for the treatment of alopecia | |
AU4364400A (en) | Azaindole derivatives for the treatment of depression | |
AU7731700A (en) | Low dose ifn-gamma for treatment of disease | |
AU2001260834A1 (en) | The treatment of herpes | |
AU2670600A (en) | Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence | |
AU1243101A (en) | High dose folic acid for the treatment of hyperhomocysteinemia | |
AU3669700A (en) | 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient | |
HUP0103788A2 (en) | Processes for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives | |
AU2021601A (en) | Composition for the treatment of dandruff | |
AUPQ365299A0 (en) | Anthranilic acid derivatives | |
AU7653600A (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis | |
HUP0203045A3 (en) | 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use | |
AU7958000A (en) | Process for the preparation of oxyiminoalkanoic acid derivatives | |
HK1043938A1 (en) | Composition for the treatment of psoriasis | |
AU2001282410A1 (en) | N-benzylindole-3-acetic acid derivatives for use in the treatment of drug resistan cancer | |
AU2683500A (en) | Compositions for the treatment of pain | |
AU3445400A (en) | The preparation of (trans)-4-amino-2-cyclopentene-1-carboxylic acid derivatives | |
AU4116500A (en) | The use of alpha lipoic acid in the antimetastatic treatment | |
AU5416500A (en) | Pharmaceutical composition for the treatment of calcification |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |